Breast cancer: From estrogen to androgen receptor

Molecular and Cellular Endocrinology

Volumn 193, Issue 1-2, 2002, Pages 121-128

  Ando S ^a   De Amicis, F ^a   Rago, V ^a   Carpino, A ^a   Maggiolini, M ^a   Panno, M L ^a   Lanzino, M ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Androgen; Breast cancer; estrogen

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIOL; ESTRADIOL; ESTROGEN; HYDROXYFLUTAMIDE; LUCIFERASE; MUTANT PROTEIN; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; ANDROSTANE DERIVATIVE;

BREAST CANCER; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; DRUG ANTAGONISM; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MODEL; MUTATION; PLASMID; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANDROSTENOLS; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESTRADIOL; FEMALE; HUMANS; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ANDROGEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037205898     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00105-3     Document Type: Article

References (31)

1. The excretion of 17-ketosteroids in the urine of patients with carcinoma of the breast
2. CREB-binding protein in androgen receptor-mediated signalling
3. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
4. Androgens induce divergent proliferative responses in human breast cancer cell lines
5. Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line
6. Hormones are ambiguous factors for breast cancer
7. Identification of women at high risk of breast cancer
8. Relationship of serum DHEA, DHEAS and 5-androstene-3β,17β-diol to risk of breast cancer in postmenopausal women
9. WAF1, a potential mediator of p53 tumor suppression
10. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassay in human breast tumor cytosols
11. Relationship of serum level of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the risk of developing postmenopausal breast cancer
12. Relationship of prediagnostic serum level of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the risk of developing premenopausal breast cancer
13. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell and promoter specific action of these hormones
14. Estrogen receptor interaction with coactivators and corepressors
15. Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells
16. Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter
17. 1
18. Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells
19. Nuclear receptor coregulators: cellular and molecular biology
20. Expression and hormonal regulation of corepressor and coactivator genes
21. Promoter context and response element-dependent specificity of transcriptional activation and modulating functions of retinoic acid receptors
22. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling
23. Androgen induced inhibition of proliferation in human breast cancer MCF-7 cells transfected with androgen receptor
24. Characterization and expression of a cDNA encoding the human androgen receptor
25. Estrogen and progesterone receptor determinations in breast cancer
26. Mitogenic stimulation of human breast cancer in a growth-factor-defined medium: synergistic action of insulin and estrogen
27. Increase of androgen-induced cell death and androgen receptor transactication by BRCA1 in prostate cancer cells
28. Aminoacid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance
29. Abnormal 24-hrs mean plasma concentration of DHEA and DHEAS in women with primary operable breast cancer
30. Abnormal 24-hrs mean plasma concentration of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the risk of developing premenopausal breast cancer